CG Oncology's CEO and a top officer buy $2.7 million of its shares

CG Oncology's chief executive and chief commercial officer bought about $2.7 million of its shares on November 18, two days after positive Phase 3 trial results.

The purchases

2 insiders
Purchase on Nov 18, filed on Nov 18
2
Buyers
$2.67M
Bought
0
Sellers

Chief executive

AK
Arthur Kuan
Buy · $2.37M · 30,000 shares
+15.1%

Other executive

IK
Isabel Kalofonos
Buy · $299.16k · 3,751 shares
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.

AI analysis

Nov 18
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.

The whole feed is waiting

Sign in to read every post and follow wallets.
Sign in